Nyxoah (NYXH) said Wednesday it launched its Genio neurostimulator system in the Netherlands, with the first successful implants done at OLVG West in Amsterdam and Zuyderland Hospital in Heerlen in patients with obstructive sleep apnea.
Shares were nearly 9% higher in premarket trade.